Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-23-036064)

Filing Details

Accession Number:: 0001209191-23-036064
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-06-09 19:38:32
Reporting Period:: 2023-06-07

Accepted Time:: 2023-06-09 19:38:32
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
921299	Fibrogen Inc	FGEN	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1775295	Christine Chung	C/O Fibrogen, Inc. 409 Illinois St. San Francisco CA 94158	Svp, China Operations	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-06-07	1,362	$17.04	251,098	No	4	S	Direct
Common Stock	Disposition	2023-06-07	739	$17.04	250,359	No	4	S	Direct
Common Stock	Disposition	2023-06-07	1,532	$17.04	248,827	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.